Although esophageal carcinoma is a relatively uncommon cancerin Western countries, there has been a rising incidence of adenocarcinomaof the esophagus and increasing mortality due to that diseasein the United States and several European countries.1 In particular,adenocarcinomas of the esophagogastric junction, the distalesophagus, and the gastric cardia have all been increasing inincidence.
The recent epidemiologic shift in esophageal carcinoma in Westerncountries from squamous-cell carcinoma associated with smokingand alcohol abuse to adenocarcinoma associated with Barrett'smetaplasia might be attributed to the increasing incidence ofobesity and obesity-induced chronic gastroesophageal refluxdisease.2 Systematic screening for . . . [Full Text of this Article]
Related Letters:
Surgical Treatment of Esophageal Cancer
Kocher H. M., Tekkis P. P., Knisely J. P.S., Burtness B. A., Salem R. R., van Lanschot J. J. B., Tilanus H. W., Obertop H., Kitajima M., Kitagawa Y., Ozawa S.
Extract |
Full Text |
PDF
N Engl J Med 2003;
348:1177-1179, Mar 20, 2003.
Correspondence
This article has been cited by other articles:
Chirieac, L. R., Swisher, S. G., Correa, A. M., Ajani, J. A., Komaki, R. R., Rashid, A., Hamilton, S. R., Wu, T.-T.
(2005). Signet-Ring Cell or Mucinous Histology after Preoperative Chemoradiation and Survival in Patients with Esophageal or Esophagogastric Junction Adenocarcinoma. Clin. Cancer Res.
11: 2229-2236
[Abstract][Full Text]
Rice, T. W., Adelstein, D. J., Chidel, M. A., Rybicki, L. A., DeCamp, M. M., Murthy, S. C., Blackstone, E. H.
(2003). Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma. J. Thorac. Cardiovasc. Surg.
126: 1590-1596
[Abstract][Full Text]
Kocher, H. M., Tekkis, P. P., Knisely, J. P.S., Burtness, B. A., Salem, R. R., van Lanschot, J. J. B., Tilanus, H. W., Obertop, H., Kitajima, M., Kitagawa, Y., Ozawa, S.
(2003). Surgical Treatment of Esophageal Cancer. NEJM
348: 1177-1179
[Full Text]